Global Custom Market Research Reports Provider Company

phone

Apogenix AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 24 Jul 2018
  • Number of Pages: 20
  • Category: Company Profile
  • Country: Germany
Summary

Apogenix AG (Apogenix) is a developer of immuno-oncology medicines for the treatment of oncological and malignant hematological diseases. The companys pipeline drug candidates under clinical development include APG101, a CD95 ligand inhibitor for the treatment of glioblastoma and myelodysplastic syndromes. Apogenix has developed the proprietary HERA technology platform for the construction of novel hexavalent receptor agonists for the treatment of cancer. It also conducts preclinical and clinical studies for various tumor indications. The company partners with other pharmaceutical and biotechnology companies and collaborates with academic institutions for the preclinical, clinical development and commercialization of its proprietary drug candidates. Apogenix is headquartered Heidelberg, Germany.

Apogenix AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData




Apogenix AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Apogenix AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Apogenix AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Apogenix AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Apogenix AG, Medical Devices Deals, 2012 to YTD 2018 9
Apogenix AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Apogenix AG, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Apogenix Secures US$9.8 Million In Venture Financing 11
Licensing Agreements 12
CANbridge Life Sciences Extends Licensing Agreement with Apogenix 12
AbbVie Enters into Licensing Agreement with Apogenix 1
Apogenix AG - Key Competitors 14
Apogenix AG - Key Employees 15
Apogenix AG - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
Sep 1, 2017: CrownBios Integrated Oncology Platform Helps Advance Apogenixs Promising HERA-GITRL Immunotherapy for NSCLC and Head and Neck Cancer 17
Mar 20, 2017: Apogenix Presents Data on Novel Hexavalent TNF Receptor Agonists (HERA) at the Upcoming Annual Meeting of the American Association for Cancer Research (AACR) 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables

List of Tables
Apogenix AG, Pharmaceuticals & Healthcare, Key Facts 2
Apogenix AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Apogenix AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Apogenix AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Apogenix AG, Deals By Therapy Area, 2012 to YTD 2018 8
Apogenix AG, Medical Devices Deals, 2012 to YTD 2018 9
Apogenix AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Apogenix Secures US$9.8 Million In Venture Financing 11
CANbridge Life Sciences Extends Licensing Agreement with Apogenix 12
AbbVie Enters into Licensing Agreement with Apogenix 13
Apogenix AG, Key Competitors 14
Apogenix AG, Key Employees 15

List Of Figures

List of Figures
Apogenix AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Apogenix AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Apogenix AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Apogenix AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Apogenix AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Apogenix AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Apogenix AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Apogenix AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Apogenix AG, Medical Devices Deals, 2012 to YTD 2018 9

ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate

View Report

US Physical Therapy Inc (USPh) operates outpatient physical and occupational therapy clinics that offer pre-and post-operative care. The company provides treatment for orthopedic-related disorders, preventative care, sports-related injuries, rehabilitation of

View Report

University of Copenhagen (UCPH) is a university and research institution that offers educational and research programs and services. The university services include graduate and undergraduate courses, research programs, masters programs,

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports